Open tenders for Amgen

Tenders that fit what Amgen offers

Closest in meaning to its products: Biotechnology therapies for serious diseases · Biotechnology company developing and manufacturing therapies for serious diseases, operating in France. Tenders in other languages match too. Best fit first, top 20 of 37.

• Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Dec 2028 · closes in 781 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 29 Rituximab (nur Fertigarzneimittel)

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Nov 2028 · closes in 750 days151 companies won similar tenders

• UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  FranceHospices Civils de LyonMedicinal products for the blood and blood-forming organs
  31 Jul 2029 · closes in 993 days26 companies won similar tenders

• Open-House-Biologika-Rabattverträge 2024-10 - Pertuzumab / Trastuzumab (Wirkstoffkombination)

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Dec 2026 · closes in 50 days151 companies won similar tenders

• PRESTATIONS DE TRANSPORT DE PRODUITS BIOLOGIQUES

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  FranceEtablissement français du sang - Ile de FranceTransport services (excl. Waste transport)est. €6.7M
  16 Nov 2026 · closes in 5 days259 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 26 - Tralokinumab

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Jul 2028 · closes in 628 days151 companies won similar tenders

• Open House Originale Rabattverträge 2025-01 - Bictegravir/Emtricitabin/Tenofoviralafenamid (Biktarvy(R))

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  28 Feb 2027 · closes in 109 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 17 Interferon beta-1b (Fertigarzneimittel: Betaferon(R))

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Jun 2028 · closes in 597 days151 companies won similar tenders

• FOURNITURE ET LIVRAISON DE MATERIELS DE PRELEVEMENT, CONSOMMABLES ET PETITS MATERIELS POUR LE LABORATOIRE DE BIOLOGIE MEDICALE CENTRE D'EXAMEN DE SANTE DE LA CAISSE PRIMAIRE CENTRALE D’ASSURANCE MALADIE DES BOUCHES-DU-RHONE

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  FranceCPCAM DES BOUCHES-DU-RHONEDisposable non-chemical medical consumables and haematological consumablesest. €214k
  3 Dec 2026 · closes in 22 days397 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 15 Ranibizumab

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Jun 2027 · closes in 231 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 20 - Peginterferon beta 1a

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Jul 2028 · closes in 628 days151 companies won similar tenders

• Fourniture de spécialités pharmaceutiques : médicaments (98 lots) au groupement GAULoYS

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  FranceCentre Hospitalier de l'Agglomération de NeversPharmaceutical products
  30 Nov 2026 · closes in 19 days151 companies won similar tenders

• Open-House-Biologika-Rabattverträge 2026-04 - Natalizumab i.v.

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Apr 2028 · closes in 536 days151 companies won similar tenders

• Open-House-Biologika-Rabattverträge 2025-02 - Rituximab (Darreichungsform zur subkutanen Injektion)

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  28 Feb 2027 · closes in 109 days151 companies won similar tenders

• Open-House-Biologika-Rabattverträge 2025-03 - Interferon beta-1a (Fertigarzneimittelbezeichnung: Avonex(R))

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Apr 2027 · closes in 170 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 12 Epoetin alfa und Epoetin zeta

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  30 Jun 2028 · closes in 597 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026 - 28 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Oct 2028 · closes in 720 days151 companies won similar tenders

• Open-House-Biologika-Rabattverträge 2025-15

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Jul 2027 · closes in 262 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026-23 - Darbepoetin alfa

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Jul 2028 · closes in 628 days151 companies won similar tenders

• Open House Biologika Rabattverträge 2026-22 - Ustekinumab

  Fits: Biotechnology company developing and manufacturing therapies for serious diseases, operating in France

  GermanyTechniker KrankenkassePharmaceutical products
  31 Jul 2027 · closes in 262 days151 companies won similar tenders